Early last week, Massachusetts based venture fund BioVentures Investors LLC closed its fourth fund at $87 million. Aimed to fuel innovation and breakthroughs in healthcare, the fourth fund raised investments for top medical technology companies.
The fund aims to foster key transformations for those involved in healthcare, including patients, physicians and institutions, by combining inventive engineering and biotechnology with the top clinical research.
Fund IV has made four investments to date, which include investments in Deep Vein Medical, an enterprise committed to combating deep venous reflex, CoNextions Medical, a tendon repair technology company, Endotronix, a wireless heart monitoring company, and Locemia Solutions, a company focused on treating hypoglycemia.
BioVentures Investors has raised more than $220 million in four funds, all dedicated to developing the MedTech industry.
